X4 Pharmaceuticals, Inc.
ACYCLIC CXCR4 INHIBITORS AND USES THEREOF

Last updated:

Abstract:

The present invention relates to compounds and methods useful for modulation, e.g. inhibition, of C-X-C receptor type 4 (CXCR4). The invention also provides pharmaceutically acceptable compositions comprising compounds of the present invention and methods of using the compositions in the treatment of various disorders.

Status:
Application
Type:

Utility

Filling date:

18 Dec 2018

Issue date:

14 Jan 2021